rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

29 Jul,12:12
7022.50
-150.80 (-2.10%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

901 7,173.30 7,299.95 - 7,022.45 7,550.00 - 3,730.00 17,556.25
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

29 Jul,12:15
7035.85
-136.75 (-1.91%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

9,298 7172.6 7,234.35 - 7,020.65 7,572.20 - 3,750.00 660.88

News for AstraZeneca Pharma India Ltd.

Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
AstraZeneca...
AstraZeneca Withdraws COVID Vaccine: Surplus of Updated Vaccines
AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...
May 08, 2024 14:34
AstraZeneca...
AstraZeneca Withdraws COVID-19 Vaccine: Surplus of Updated Shots
AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.
May 08, 2024 11:12
Covaxin Safe, No...
Covaxin Safe, No Side Effects: Bharat Biotech
Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.
May 02, 2024 21:41
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:17

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

Byju Raveendran's...
Byju Raveendran's Byju Insolvency Plea Adjourned at NCLAT
Byju Raveendran's plea against insolvency proceedings of Byju's (Think & Learn) was adjourned at NCLAT as a judge recused himself. The matter will now be heard by a different bench.
Jul 29, 2024 12:09
Honeywell & Air...
Honeywell & Air India Sign Long-Term APU Maintenance Deal
Honeywell has signed a long-term agreement with Air India for the maintenance of Auxiliary Power Units (APUs) across the airline's existing and new fleet.
Jul 29, 2024 11:26
Bandhan Bank...
Bandhan Bank Shares Surge 13% After Strong Q1 Earnings
Bandhan Bank shares rallied over 13% on Monday after the private lender reported a 47% jump in net profit for the June quarter, driven by improved asset quality.
Jul 29, 2024 11:22
ICICI Bank Shares...
ICICI Bank Shares Surge 3% After Strong Earnings
ICICI Bank shares climbed nearly 3% on Monday after the company reported a 10% increase in consolidated net profit for the June quarter, driven by strong treasury gains.
Jul 29, 2024 11:08
L''T Wins...
L''T Wins Substation, Transmission Line Projects in India, Overseas
Larsen ''Toubro (L''T) has secured new projects in India and overseas for building substations and transmission lines, contributing to clean energy transition and grid strengthening.
Jul 29, 2024 10:55

More News »

Top News

Byju Raveendran's...
Byju Raveendran's Byju Insolvency Plea Adjourned at NCLAT
Byju Raveendran's plea against insolvency proceedings of Byju's (Think & Learn) was adjourned at NCLAT as a judge recused himself. The matter will now be heard by a different bench.
Jul 29, 2024 12:09
Manu Bhaker Wins Bronze at Paris Olympics: Lok Sabha Congratulates
Lok Sabha congratulates Manu Bhaker for winning bronze medal in the 10m air pistol event at the Paris Olympics, ending India's 12-year wait for a shooting medal.
Jul 29, 2024 11:50
Pakistan Seeks...
Pakistan Seeks Debt Reprofiling with China, Saudi Arabia, UAE
Pakistan seeks to re-profile over USD 27 billion in debt with China, Saudi Arabia and UAE to secure IMF bailout. This includes extending maturity periods of loans and converting energy sector...
Jul 29, 2024 11:38
Honeywell & Air...
Honeywell & Air India Sign Long-Term APU Maintenance Deal
Honeywell has signed a long-term agreement with Air India for the maintenance of Auxiliary Power Units (APUs) across the airline's existing and new fleet.
Jul 29, 2024 11:26
Bandhan Bank...
Bandhan Bank Shares Surge 13% After Strong Q1 Earnings
Bandhan Bank shares rallied over 13% on Monday after the private lender reported a 47% jump in net profit for the June quarter, driven by improved asset quality.
Jul 29, 2024 11:22

More Top News »

Report Card

PE Ratios
110.83
EPS (Rs.)
64.60
Sales (Rs. Cr)
383.20
Face Value (Rs.)
2
Net Profit Margin (%)
12.46
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
22.68

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,665.20
  • Compare
  • Divi's Laboratories Ltd.
  • 4,549.75
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,205.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,854.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,087.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,388.60
  • Compare
  • Max Healthcare Institute Ltd.
  • 926.50
  • Compare
  • Alkem Laboratories Ltd.
  • 5,178.80
  • Compare

Most Active

  • Change (Rs.)
  •  

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close